165 related articles for article (PubMed ID: 37537749)
21. Expression of c-FLIP in gastric cancer and its relation to tumor cell proliferation and apoptosis.
Ryang DY; Joo YE; Chung KM; Lim SR; Jeong HK; Kim HI; Lee WS; Park CH; Kim HS; Choi SK; Rew JS; Lee JH; Park CS
Korean J Intern Med; 2007 Dec; 22(4):263-9. PubMed ID: 18309685
[TBL] [Abstract][Full Text] [Related]
22. Epigallocatechin gallate reverses gastric cancer by regulating the long noncoding RNA LINC00511/miR-29b/KDM2A axis.
Zhao Y; Chen X; Jiang J; Wan X; Wang Y; Xu P
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165856. PubMed ID: 32512188
[TBL] [Abstract][Full Text] [Related]
23. ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
Le Clorennec C; Lazrek Y; Dubreuil O; Sampaio C; Larbouret C; Lanotte R; Poul MA; Barret JM; Prost JF; Pèlegrin A; Chardès T
Cell Commun Signal; 2019 Aug; 17(1):106. PubMed ID: 31443721
[TBL] [Abstract][Full Text] [Related]
24. Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation.
Chen H; Landen CN; Li Y; Alvarez RD; Tollefsbol TO
Exp Cell Res; 2013 Mar; 319(5):697-706. PubMed ID: 23333498
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of c-FLIP by RNAi enhances sensitivity of the human osteogenic sarcoma cell line U2OS to TRAIL-induced apoptosis.
Zhang YP; Kong QH; Huang Y; Wang GL; Chang KJ
Asian Pac J Cancer Prev; 2015; 16(6):2251-6. PubMed ID: 25824746
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of FLIP(S) by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers.
Nam SY; Jung GA; Hur GC; Chung HY; Kim WH; Seol DW; Lee BL
Cancer Sci; 2003 Dec; 94(12):1066-73. PubMed ID: 14662022
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells.
Gupta S; Hussain T; Mukhtar H
Arch Biochem Biophys; 2003 Feb; 410(1):177-85. PubMed ID: 12559991
[TBL] [Abstract][Full Text] [Related]
28. Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals.
Abou El Naga RN; Azab SS; El-Demerdash E; Shaarawy S; El-Merzabani M; Ammar el-SM
Life Sci; 2013 Mar; 92(10):555-61. PubMed ID: 23352978
[TBL] [Abstract][Full Text] [Related]
29. Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate.
Hastak K; Agarwal MK; Mukhtar H; Agarwal ML
FASEB J; 2005 May; 19(7):789-91. PubMed ID: 15764647
[TBL] [Abstract][Full Text] [Related]
30. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
31. SIRT1 Deficiency, Specifically in Fibroblasts, Decreases Apoptosis Resistance and Is Associated with Resolution of Lung-Fibrosis.
Bulvik R; Breuer R; Dvir-Ginzberg M; Reich E; Berkman N; Wallach-Dayan SB
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32630813
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of Epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression.
Yan C; Yang J; Shen L; Chen X
Arch Gynecol Obstet; 2012 Feb; 285(2):459-67. PubMed ID: 21698451
[TBL] [Abstract][Full Text] [Related]
33. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
Kim SO; Kim MR
Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
[TBL] [Abstract][Full Text] [Related]
34. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
Yamauchi R; Sasaki K; Yoshida K
Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
[TBL] [Abstract][Full Text] [Related]
35. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH
World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194
[TBL] [Abstract][Full Text] [Related]
36. Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy.
McCourt C; Maxwell P; Mazzucchelli R; Montironi R; Scarpelli M; Salto-Tellez M; O'Sullivan JM; Longley DB; Waugh DJ
Clin Cancer Res; 2012 Jul; 18(14):3822-33. PubMed ID: 22623731
[TBL] [Abstract][Full Text] [Related]
37. Apoptotic effect of Epigallocatechin-3-gallate on the human gastric cancer cell line MKN45 via activation of the mitochondrial pathway.
Ran ZH; Xu Q; Tong JL; Xiao SD
World J Gastroenterol; 2007 Aug; 13(31):4255-9. PubMed ID: 17696257
[TBL] [Abstract][Full Text] [Related]
38. [Epigallocatechin-3-gallate induces G1 phase cell cycle arrest in KB cells].
Jiang S; Chen XL; Ding Y; Chen ZW; Zhu LJ; Feng H; Zhen MC; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1381-3. PubMed ID: 19620059
[TBL] [Abstract][Full Text] [Related]
39. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation.
Fan S; Li Y; Yue P; Khuri FR; Sun SY
Neoplasia; 2010 Apr; 12(4):346-56. PubMed ID: 20360945
[TBL] [Abstract][Full Text] [Related]
40. Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (-)-epigallocatechin-3-gallate (EGCG).
Nihal M; Roelke CT; Wood GS
Pharm Res; 2010 Jun; 27(6):1103-14. PubMed ID: 20232120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
